118 related articles for article (PubMed ID: 26239171)
1. MicroRNA‑214 promotes proliferation and inhibits apoptosis via targeting Bax in nasopharyngeal carcinoma cells.
He J; Tang Y; Tian Y
Mol Med Rep; 2015 Oct; 12(4):6286-92. PubMed ID: 26239171
[TBL] [Abstract][Full Text] [Related]
2. The role and underlying mechanisms of microRNA‑214 in Legg‑Calvé‑Perthes disease.
Zhu H; Qi X; Liu Y; Liao W; Sun X; Tang Y
Mol Med Rep; 2019 Jul; 20(1):685-692. PubMed ID: 31180556
[TBL] [Abstract][Full Text] [Related]
3. Role of the microRNA‑214/Bax axis in the progression of acute liver failure.
Wu S; Huang X; Sun W; Chen L; Huang Y; Wang Y; Luo E; Qin A; Zhao W; Gan J
Mol Med Rep; 2020 Jul; 22(1):117-126. PubMed ID: 32377732
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
Shan H; Zhou X; Chen C
Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
[TBL] [Abstract][Full Text] [Related]
5. miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells.
Liu J; Bi J; Li Z; Li Z; Liu X; Kong C
Int J Mol Med; 2018 Mar; 41(3):1765-1773. PubMed ID: 29328435
[TBL] [Abstract][Full Text] [Related]
6. Mangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line.
Pan LL; Wang AY; Huang YQ; Luo Y; Ling M
Asian Pac J Cancer Prev; 2014; 15(17):7065-8. PubMed ID: 25227792
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑214 targets Wnt3a to suppress liver cancer cell proliferation.
Yang Y; Zhao Z; Hou N; Li Y; Wang X; Wu F; Sun R; Han J; Sun H; Song T; Huang C; Shao Y
Mol Med Rep; 2017 Nov; 16(5):6920-6927. PubMed ID: 28901526
[TBL] [Abstract][Full Text] [Related]
9. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
10. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
12. [Down-regulation of miR-205-5p enhances pro-apoptotic effect of 3-bromopyruvate on human nasopharyngeal carcinoma CNE2Z cells].
Shi Z; Zhang P; Lu X; Zhu C; Chen C; Zhao S; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1166-1172. PubMed ID: 31801705
[TBL] [Abstract][Full Text] [Related]
13. Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells.
Zhang C; Fang X; Li W; Shi Q; Wu L; Chen X; Huang Z; Wu P; Wang Z; Liao Z
Cancer Biother Radiopharm; 2014 Dec; 29(10):422-7. PubMed ID: 25405832
[TBL] [Abstract][Full Text] [Related]
14. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10.
Liu F; Lou K; Zhao X; Zhang J; Chen W; Qian Y; Zhao Y; Zhu Y; Zhang Y
Int J Mol Med; 2018 Dec; 42(6):3027-3036. PubMed ID: 30272290
[TBL] [Abstract][Full Text] [Related]
15. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
He W; Jin H; Liu Q; Sun Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
[TBL] [Abstract][Full Text] [Related]
16. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells.
Pan X; Peng G; Liu S; Sun Z; Zou Z; Wu G
Int J Mol Med; 2015 Aug; 36(2):559-64. PubMed ID: 26081980
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑214 promotes the EMT process in melanoma by downregulating CADM1 expression.
Wang SJ; Li WW; Wen CJ; Diao YL; Zhao TL
Mol Med Rep; 2020 Nov; 22(5):3795-3803. PubMed ID: 33000202
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
Huang S; Li X; Zhu H
Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
